Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules

计划入组 60 人 · 首次发布于 2018 年 1 月 23 日

Experimental Human Pneumococcal Challenge with Streptococcus pneumoniae serotype 3

计划入组 83 人

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

计划入组 106 人 · 首次发布于 2024 年 12 月 12 日

pneumococcus vaccine

Cyd dengue virus serotype 3 live (attenuated) antigen(Dengvaxia)

Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen(Prevnar 13, Prevnar 20, Vaxneuvance)

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

iiCON-Supported Phase II Trial to Advance Novel Pneumococcal Vaccine, PnuBioVax

iiCON-Supported Phase II Trial Aims to Combat Pneumococcal Disease with Novel Vaccine

Vaxcyte's VAX-24 Shows Promising Results Despite Phase 2 Serotype Misses in Infant Study